80 FR 52325 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 167 (August 28, 2015)

Page Range		52325-52325
FR Document		2015-21378

Federal Register, Volume 80 Issue 167 (Friday, August 28, 2015)

[Federal Register Volume 80, Number 167 (Friday, August 28, 2015)]
[Notices]
[Page 52325]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-21378]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Implementation 
(R01).
    Date: September 22, 2015.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3G33, 5601 Fishers 
Lane, Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Andrea L Wurster, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G33B, National Institutes of Health, NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20899823, (240) 669-5062, 
[email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Clinical Trial Planning Grant 
(R34).
    Date: September 25, 2015.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Room 3G33, 5601 Fishers 
Lane, Rockville, MD 20892, (Telephone Conference Call).
    Contact Person: Andrea L Wurster, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G33B, National Institutes of Health, NIAID, 5601 
Fishers Lane, MSC 9823, Bethesda, MD 20899823, (240) 669-5062, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 25, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-21378 Filed 8-27-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 167 / Friday, August 28, 2015 / Notices 52325

Opportunity on (301) 458–4EEO (4336) Bethesda, MD 20899823, (240) 669–5062, your address to: rothmann@
as soon as possible. wurstera@mail.nih.gov. mail.nih.gov. Formal requests for
(Catalogue of Federal Domestic Assistance additional plans and instruments must
Dated: August 24, 2015.
Program Nos. 93.855, Allergy, Immunology, be requested in writing.
James Scanlon, and Transplantation Research; 93.856, Comment Due Date: Comments
Deputy Assistant Secretary for Planning and Microbiology and Infectious Diseases regarding this information collection are
Evaluation (Science and Data Policy), Office Research, National Institutes of Health, HHS)
of the Assistant Secretary for Planning and
best assured of having their full effect if
Dated: August 25, 2015. received within 60 days of the date of
Evaluation.
David Clary, this publication.
[FR Doc. 2015–21328 Filed 8–27–15; 8:45 am]
Program Analyst, Office of Federal Advisory Proposed Collection: A Multi-Center
BILLING CODE 4151–05–P
Committee Policy. International Hospital-Based Case-
[FR Doc. 2015–21378 Filed 8–27–15; 8:45 am] Control Study of Lymphoma in Asia
DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P (AsiaLymph) (NCI), 0925–0654,
Expiration Date 10/31/2015–REVISION,
HUMAN SERVICES
National Institutes of Health (NIH).
National Institutes of Health DEPARTMENT OF HEALTH AND Need and Use of Information
HUMAN SERVICES Collection: Incidence rates of certain
National Institute of Allergy and lymphomas have increased in the
Infectious Diseases; Notice of Closed National Institutes of Health United States and in many other parts
Meetings of the world. The contribution of
Proposed Collection; 60-day Comment environmental, occupational, and
Pursuant to section 10(d) of the Request: A Multi-Center International genetic factors to the cause of
Federal Advisory Committee Act, as Hospital-Based Case-Control Study of lymphoma and leukemia has generated
amended (5 U.S.C. App.), notice is Lymphoma in Asia (AsiaLymph) (NCI) a series of novel findings from
hereby given of the following meetings. epidemiological studies conducted in
SUMMARY: In compliance with the
The meetings will be closed to the the United States that have attempted to
requirement of Section 3506(c)(2)(A) of
public in accordance with the explain this increase. However, none of
the Paperwork Reduction Act of 1995,
provisions set forth in sections the chemical associations have been
for opportunity for public comment on
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., conclusively established and the
proposed data collection projects, the
as amended. The grant applications and identification of the key, functional
National Cancer Institute, the National
the discussions could disclose alleles in gene regions associated with
Institutes of Health (NIH) will publish
confidential trade secrets or commercial risk of lymphoma requires further
periodic summaries of proposed
property such as patentable material, elucidation. Further, the ability to
projects to be submitted to the Office of
and personal information concerning follow-up, confirm, and extend these
Management and Budget (OMB) for
individuals associated with the grant review and approval. observations in the United States is
applications, the disclosure of which Written comments and/or suggestions limited by the low prevalence and
would constitute a clearly unwarranted from the public and affected agencies limited range of several important
invasion of personal privacy. are invited to address one or more of the chemical and viral exposures and the
Name of Committee: National Institute of following points: (1) Whether the high to complete linkage disequilibrium
Allergy and Infectious Diseases Special proposed collection of information is among key candidate genetic loci in
Emphasis Panel; NIAID Clinical Trial necessary for the proper performance of Western populations. To optimize the
Implementation (R01). the function of the agency, including ability to build on and clarify these
Date: September 22, 2015. findings, it is necessary to investigate
Time: 12:00 p.m. to 2:00 p.m.
whether the information will have
practical utility; (2) The accuracy of the populations that differ from those in the
Agenda: To review and evaluate grant
applications. agency’s estimate of the burden of the West in both exposure patterns and
Place: National Institutes of Health, Room proposed collection of information, underlying genetic structure. A
3G33, 5601 Fishers Lane, Rockville, MD including the validity of the multidisciplinary case-control study of
20892, (Telephone Conference Call). methodology and assumptions used; (3) lymphoma in Asia, where lymphoma
Contact Person: Andrea L Wurster, Ph.D., The quality, utility, and clarity of the rates have also risen, provides an
Scientific Review Officer, Scientific Review information to be collected; and (4) opportunity to replicate and extend
Program, Division of Extramural Activities, Minimize the burden of the collection of recent and novel observations made in
Room 3G33B, National Institutes of Health, studies in the West in a population that
NIAID, 5601 Fishers Lane, MSC 9823,
information on those who are to
respond, including the use of is distinctly different with regard to
Bethesda, MD 20899823, (240) 669–5062,
wurstera@mail.nih.gov. appropriate automated, electronic, patterns of key risk factors, including
mechanical, or other technological range of exposures, prevalence of
Name of Committee: National Institute of
Allergy and Infectious Diseases Special collection techniques or other forms of exposures, correlations between
Emphasis Panel; NIAID Clinical Trial information technology. exposures, and variation in gene regions
Planning Grant (R34). To Submit Comments and for Further of particular interest. It will also
Date: September 25, 2015. Information: To obtain a copy of the improve the ability to understand the
Time: 10:00 a.m. to 12:00 p.m. data collection plans and instruments, causes of certain types of rare
Agenda: To review and evaluate grant submit comments in writing, or request lymphoma tumors in the United States
applications. more information on the proposed that occur at much higher rates in Asia.
Lhorne on DSK5TPTVN1PROD with NOTICES

Place: National Institutes of Health, Room project, contact: Nathaniel Rothman, As such, AsiaLymph will confirm and
3G33, 5601 Fishers Lane, Rockville, MD
Senior Investigator, Division of Cancer extend previous findings and yield
20892, (Telephone Conference Call).
Contact Person: Andrea L Wurster, Ph.D., Epidemiology and Genetics, 9609 novel insights into the causes of
Scientific Review Officer, Scientific Review Medical Center Drive, MSC 9776, Room lymphoma and leukemia in both Asia
Program, Division of Extramural Activities, 6E134, Bethesda, Maryland 20892 or and in the United States. The major
Room 3G33B, National Institutes of Health, call non-toll-free number (240) 276– postulated risk factors for evaluation in
NIAID, 5601 Fishers Lane, MSC 9823, 7169 or Email your request, including this study are chemical exposures (i.e.,

VerDate Sep<11>2014 14:19 Aug 27, 2015 Jkt 235001 PO 00000 Frm 00081 Fmt 4703 Sfmt 4703 E:\FR\FM\28AUN1.SGM 28AUN1

Document Created: 2015-12-15 11:04:28
Document Modified: 2015-12-15 11:04:28

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 22, 2015.
FR Citation		80 FR 52325

80 FR 52325 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 167 (August 28, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health